Fact CheckerSign in

NCT06442891Completed

Self-Administered Relaxing Acupressure to Reduce Fatigue in Adolescent and Young Adult Cancer Survivors

A Pilot Study of Self-Administered Acupressure for Fatigue Among Adolescent and Young Adult (AYA) Cancer Survivors

Source: ClinicalTrials.gov · Last updated 23 Jun 2026

Brief summary (registry, in English)

This clinical trial tests the feasibility of self-administered relaxing acupressure on fatigue in adolescent and young adult (AYA) cancer survivors. Acupressure, a type of complementary or alternative medicine, is the application of pressure or localized massage to specific sites on the body to control symptoms. Relaxing acupressure has been shown to improve cancer-related fatigue (CRF) in adults, however, less is known about the impact of relaxing acupressure on CRF in AYA cancer survivors."

Status (registry)
Completed
Study type
Interventional
Enrollment
42 (actual)
First submitted
30 May 2024
Start date
1 Oct 2024
Primary completion date
22 Dec 2025
Lead sponsor
University of Michigan Rogel Cancer Center
NCT number
NCT06442891

What you commit to

  • Study type: Interventional
  • Participants enrolled: 42
  • From 1 Oct 2024 to the primary completion date, 22 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Plan to begin new pharmacological, psychological, or other treatments (i.e., physical therapy or dietary supplements) for CRF during the study. Although, participants may continue usual treatments for CRF if the treatments were initiated at least eight weeks prior to study enrollment, and the dose has not changed
  • Received acupressure or acupuncture in the past year

Other illness

  • Diagnosis of untreated anemia, mood disorder, or hypothyroidism

Other

  • Plan to become pregnant or lactating during the study period

Who the study is looking for

  • 15 - 39 years old
  • At least three months post cancer treatment (e.g., surgery, radiation or chemotherapy). Participants receiving maintenance hormonal or targeted therapies will be allowed to enroll as determined by the study investigator
  • Report clinically relevant fatigue in the past seven days (Patient Reported Outcomes Measurement Information Systems \[PROMIS\] Fatigue 4a scores ≥ 55)
  • Speak / read English
  • CRF started at or after the diagnosis of cancer
  • Completed cancer treatment within the past five years

Age in the registry: 15 years to 39 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Of Michigan Comprehensive Cancer Center
Coordinator of this site? Confirm its status
Ann ArborUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.